Investigate the Mortality, Morbidity and Factors Associate in Thalassemia Patients in Faisalabad, Pakistan
DOI:
https://doi.org/10.70749/ijbr.v3i7.1782Keywords:
Thalassemia, Mortality, Morbidity, Risk FactorsAbstract
Introduction: Thalassemia represents a genetic blood disorder that people obtain from their parents through hereditary materials since their bodies produce abnormal types of hemoglobin. The red blood cell destruction occurs in high numbers because of this disorder thus producing anemia.It is a prevalent disease, and in our society, its prevalence is 75%, with 35% of cases in females and 40% in males. Most of the cases are of beta thalassemia major. Objective: We are conducting this research so that in the future, we can correlate the disease with comorbidity in order to reduce the prevalence and so to improve treatment. Method: The study design of this research was retrospective cross-sectional study. We made a questionnaire provided to participants for gathering data.This was followed by a peripheral blood smear to assess cell morphology. Iron deficiency tests were then conducted to rule out other causes of anemia. The questionnaire was carefully designed to gather detailed information on patient and family history, lifestyle, awareness levels, and genetic background Patients were monitored through a follow-up process. Result: The study found that 75% of participants were affected by thalassemia, with 40% males and 35% females, and most cases were beta thalassemia major. Blood tests like CBC confirmed genetic anemia, not due to iron deficiency. The majority of participants lacked awareness about the disease and its hereditary nature, highlighting the need for screening and education programs. Conclusion: In this review we will discuss about Investigate the Mortality, Morbidity and factors associate on Thalassemia patients in Faisalabad 2025Pakistan. Its prevalence rate is high about 75% which is 35% females and 40% males related to our research. Future Perspective: This study's findings will inform evidence-based healthcare policies and interventions to reduce mortality and morbidity in thalassemia patients in Faisalabad, Pakistan, ultimately improving patient outcomes and quality of life. The insights gained will also contribute to the development of targeted prevention strategies and optimized management protocols for thalassemia care in resource-constrained settings. Future research can build upon these findings to explore innovative solutions and best practices for thalassemia management in Pakistan.
Downloads
References
1. Al_Hamadiny, S. Q., Alqaisi, A. A., Al-Sarray, R. G., Ali, S. A., Trad, H. Q., & Abood, A. J. (2024). Psychosocial factors associated with major thalassemia. European Journal of Medical Genetics and Clinical Biology, 1(9), 10-15.
https://doi.org/10.61796/jmgcb.v1i9.917
2. Ansari, A. H., Ansari, S. H., Salman, M. J., Ansari, M. U., & Jabeen, R. (2024). A scoping review on the obstacles faced by beta thalassemia major patients in pakistan- Matter of policy investment. AIMS Public Health, 11(4), 1105-1124.
https://doi.org/10.3934/publichealth.2024057
3. Asif, N., & Hassan, K. (2016). Management of thalassemia in Pakistan. Journal of Islamabad Medical & Dental College, 5(4), 152-153.
https://mail.jimdc.org.pk/index.php/JIMDC/article/view/118
4. Baig, S. M., Azhar, A., Hassan, H., Baig, J. M., Aslam, M., Ud Din, M. A., Qureshi, J. A., & Zaman, T. (2006). Prenatal diagnosis of β‐thalassemia in southern Punjab, Pakistan. Prenatal Diagnosis, 26(10), 903-905.
https://doi.org/10.1002/pd.1523
5. Batool, I. R. A. M., Ishfaq, K. A. M. R. A. N., & Bajwa, R. S. (2017). Psychosocial burden among thalassemia major patients: An exploratory investigation of south Punjab, Pakistan. Pakistan Paediatr J, 41(3), 158-62.
6. Benz, E. J. (2023). Introduction to the thalassemia syndromes. Hematology/Oncology Clinics of North America, 37(2), 245-259.
https://doi.org/10.1016/j.hoc.2022.11.001
7. Galanello, R., & Origa, R. (2010). Beta-thalassemia. Orphanet Journal of Rare Diseases, 5(1).
https://doi.org/10.1186/1750-1172-5-11
8. Jabeen, R., Ansari, I., Durrani, B., Salman, M. J., Mazhar, L., Ansari, M. U., Ansari, A. H., Kabani, S., & Ansari, S. H. (2024). Exploring the perceptions and experiences of female’s with S-thalassemia major in a tertiary care private hospital in Pakistan. Transfusion Clinique et Biologique, 31(4), 244-252.
https://doi.org/10.1016/j.tracli.2024.06.008
9. Jafri, L., Jameel Farooqui, A., Moiz, B., Sheikh, A., Majid, H., Nadeem, S., Quddus, R., Khan, S., Khan, Q., & Habib Khan, A. (2025). Factors associated with phosphate homeostasis in children with beta-thalassemia major: An analytical cross sectional study from Pakistan. PLOS ONE, 20(2), e0316566.
https://doi.org/10.1371/journal.pone.0316566
10. Marsella, M., Pepe, A., & Borgna‐Pignatti, C. (2010). Better survival and less cardiac morbidity in female patients with thalassemia major: A review of the literature. Annals of the New York Academy of Sciences, 1202(1), 129-133.
https://doi.org/10.1111/j.1749-6632.2010.05588.x
11. Mashon, R. S., Mandrelle, K., & Kakkar, N. (2024). Experience of antenatal thalassemia screening and prenatal diagnosis from a tertiary care teaching hospital in Punjab. Indian Journal of Hematology and Blood Transfusion, 41(1), 96-101.
https://doi.org/10.1007/s12288-024-01785-z
12. Meri, M. A., Al-Hakeem, A. H., & Al-Abeadi, R. S. (2022). Overview on thalassemia: A review article. Medical Science Journal for Advance Research, 3(1), 26-32.
https://doi.org/10.46966/msjar.v3i1.36
13. Prathyusha, K., Venkataswamy, M., Goud, K. S., Ramanjaneyulu, K., Himabindu, J., & Raj, K. S. (2019). Thalassemia-A blood disorder, its cause, prevention and management. Research Journal of Pharmaceutical Dosage Forms and Technology, 11(3), 186.
https://doi.org/10.5958/0975-4377.2019.00033.8
14. Soliman, A., Yassin, M., Alyafei, F., Alaaraj, N., Hamed, N., Osman, S., & Soliman, N. (2023). Nutritional studies in patients with β-thalassemia major: A short review. Acta Bio Medica: Atenei Parmensis, 94(3), e2023187.
https://doi.org/10.23750/abm.v94i3.14732
15. Ghafoor, M., Sabar, M. F., & Sabir, F. (2020). Prevention programs and prenatal diagnosis for beta thalassemia in Pakistan: A narrative review. Journal of the Pakistan Medical Association, 1-17.
https://doi.org/10.47391/jpma.665
16. Ganaee, M. A., & Iqbal, M. J. (2018). Development of IIUI e-Theses collection: a case study. Pakistan Library & Information Science Journal, 49(4).
17. Arshad, B., Iqbal, T., Jamil, A., & Asan, I. J. H. (2014). Hematological and biochemical changes in male patients with thalassemia major. Pak. j. life soc. Sci, 12(1), 31-35.
https://www.pjlss.edu.pk/pdf_files/2014_1/31-35.pdf
18. Aziz, A., Tehreem, H., Aslam, R., Khan, W. A., Javed, M. U., Ali, M. S., Riaz, A., Tariq, M. N., Gilani, S. S., Noor, S., & Noor, E. (2024). Consanguineous marriages and thalassemia major in Pakistan: A cross-sectional study on awareness and prevalence. The American Journal of Medical Sciences and Pharmaceutical Research, 6(7), 49-61.
https://doi.org/10.37547/tajmspr/volume06issue07-07
19. Malik, M., Gul, Z., Bohair, J., Naeem, S. K., & Sadiq, N. (2024). Family planning practices among the parents of beta thalassemia major patients in Makran Division, Balochistan: A cross-sectional study. Pakistan Journal of Medical Sciences, 41(1), 230-234.
https://doi.org/10.12669/pjms.41.1.10263
20. Daar, S., Al-Naamani, K., De Sanctis, V., Al Rahbi, S., Zedjali, S., Khan, H., ... & Al-Khabori, M. (2023). Mortality and complications in Omani patients with beta-thalassemia major: a long-term follow-up study. Acta Bio Medica: Atenei Parmensis, 94(4), e2023191.
https://doi.org/10.23750/abm.v94i4.14856
21. Faranoush, M., Faranoush, P., Heydari, I., Foroughi‐Gilvaee, M. R., Azarkeivan, A., Parsai Kia, A., Sadighnia, N., Elahinia, A., Zandi, A., Rezvany, M. R., Hashemi‐Madani, N., Ziaee, A., Nekouian, R., & Rohani, F. (2023). Complications in patients with transfusion dependent thalassemia: A descriptive cross‐sectional study. Health Science Reports, 6(10).
https://doi.org/10.1002/hsr2.1624
22. Hussein, S. Z. (2022). Evaluation of thyroid hormones and ferritin level in patients with β- thalassemia. Medicine and Pharmacy Reports, 95(2), 152-157.
https://doi.org/10.15386/mpr-2053
23. Bizri, M., Koleilat, R., Akiki, N., Dergham, R., Mihailescu, A. M., Bou-Fakhredin, R., Musallam, K. M., & Taher, A. T. (2024). Quality of life, mood disorders, and cognitive impairment in adults with β-thalassemia. Blood Reviews, 65, 101181.
https://doi.org/10.1016/j.blre.2024.101181
24. Jewad, A. M., & Shwayel, A. J. (2024). Evaluation of some nonroutine cardiac biomarkers among adults and children with beta-thalassemia major. Laboratory Medicine, 55(5), 559-565.
https://doi.org/10.1093/labmed/lmae007
25. Khaliq, S. (2022). Thalassemia in Pakistan. Hemoglobin, 46(1), 12–14.
https://doi.org/10.1080/03630269.2022.2059670
26. Ansari, A. H., Ansari, S. H., Salman, M. J., Ansari, M. U., & Jabeen, R. (2024). A scoping review on the obstacles faced by beta thalassemia major patients in pakistan- Matter of policy investment. AIMS Public Health, 11(4), 1105-1124.
https://doi.org/10.3934/publichealth.2024057
27. Ali, S., Mumtaz, S., Shakir, H. A., Tahir, H. M., & Mughal, T. A. (2019). Current perspective of beta thalassemia and its treatment strategies.
https://doi.org/10.20944/preprints201907.0277.v1
28. Ansari, A. H., Ansari, S. H., Salman, M. J., Ansari, M. U., & Jabeen, R. (2024). A scoping review on the obstacles faced by beta thalassemia major patients in pakistan- Matter of policy investment. AIMS Public Health, 11(4), 1105-1124.
https://doi.org/10.3934/publichealth.2024057
29. Tantiworawit, A., Kamolsripat, T., Piriyakhuntorn, P., Rattanathammethee, T., Hantrakool, S., Chai-Adisaksopha, C., Rattarittamrong, E., Norasetthada, L., Fanhchaksai, K., & Charoenkwan, P. (2024). Survival and causes of death in patients with Alpha and beta-thalassemia in northern Thailand. Annals of Medicine, 56(1).
https://doi.org/10.1080/07853890.2024.2338246
30. Hussain, S., Ashfaq, M., Nisa, B., & Ally, K. (2025). Frequency of cardiac complications in beta-thalassemia patients at National Institute of child health, Karachi, Pakistan. The Professional Medical Journal, 32(03), 309-314.
https://doi.org/10.29309/tpmj/2025.32.03.8811
31. Batool, N., Saleem, Z., Saeed, H., Yasmeen, S., Anwar, R., Ahmad, F., Tauqeer, F., & Mahboob, M. (2022). Factors affecting health-related quality of life (HRQoL) in Pakistani children with thalassemia. Family Medicine & Primary Care Review, 24(1), 37-42.
https://doi.org/10.5114/fmpcr.2022.113012
32. Musallam, K. M., Rivella, S., Vichinsky, E., & Rachmilewitz, E. A. (2013). Non-transfusion-dependent thalassemias. Haematologica, 98(6), 833-844.
https://doi.org/10.3324/haematol.2012.066845
33. Borgna-Pignatti, C., & Gamberini, M. R. (2011). Complications of thalassemia major and their treatment. Expert Review of Hematology, 4(3), 353-366.
https://doi.org/10.1586/ehm.11.29
34. Cappellini, M. D., Farmakis, D., Porter, J., & Taher, A. (2021). Guidelines for the Management of Transfusion Dependent Thalassaemia (TDT) Thalassaemia International Federation. Strovolos, Cyprus.
35. Modell, B., & Darlison, M. (2008). Global epidemiology of haemoglobin disorders and derived service indicators. Bulletin of the World Health Organization, 2008(6), 480–487.
https://doi.org/10.2471/blt.06.036673
36. VICHINSKY, E. P. (2005). Changing patterns of thalassemia worldwide. Annals of the New York Academy of Sciences, 1054(1), 18-24.
https://doi.org/10.1196/annals.1345.003
37. Cohen, A. R., Galanello, R., Pennell, D. J., Cunningham, M. J., & Vichinsky, E. (2004). Thalassemia. Hematology, 2004(1), 14-34.
https://doi.org/10.1182/asheducation-2004.1.14
38. Tan, J. Y., Yeo, Y. H., Chan, K. H., Shaaban, H., & Guron, G. (2024). Causes of death and mortality trends in individuals with thalassemia in the United States, 1999-2020. Journal of Blood Medicine, 15, 331-339.
https://doi.org/10.2147/jbm.s470177
39. Dhanya, R., Agarwal, R. K., Sedai, A., Kumari, A., Parmar, L., Hegde, S., ., G., Gowda, A., Gujjal, P., H, P., Ramaiah, J. D., Karri, C., Jali, S., Tallur, N., Shenoy, U. V., Pinto, D., Ramprakash, S., Raghuram, C. P., Trivedi, D., … Faulkner, L. (2019). Assessment of mortality and its associated risk factors in patients with transfusion dependent thalassemia in India. Blood, 134(Supplement_1), 973-973.
https://doi.org/10.1182/blood-2019-125151
40. Datta, S. S., & Sinha, A. (2024). Current challenges of blood transfusions in patients with thalassemia in India and future perspectives. Transfusion Clinique et Biologique, 31(3), 162-166.
https://doi.org/10.1016/j.tracli.2024.03.004
41. Yasmeen, H., & Hasnain, S. (2019). Epidemiology and risk factors of transfusion transmitted infections in thalassemia major: A multicenter study in Pakistan. Hematology, Transfusion and Cell Therapy, 41(4), 316-323.
https://doi.org/10.1016/j.htct.2019.03.008
42. Ishfaq, K., Shabbir, M., Naeem, S. B., & Hussain, S. (2015). Impact of thalassemia major on patients. The Professional Medical Journal, 22(05), 582-589.
https://doi.org/10.29309/tpmj/2015.22.05.1271
43. Nawaz, K., Khan, S. N., Bashir, A., Rehman, A., Tariq Masood Khan, M., Mir, A., & Ahmad, S. (2024). Unraveling impact of hemoglobin F and A2 levels: Correlation with disease severity and treatment response in transfusion-dependent beta-thalassemia. Cureus.
https://doi.org/10.7759/cureus.52002
44. Sadiq, I. Z., Abubakar, F. S., Usman, H. S., Abdullahi, A. D., Ibrahim, B., Kastayal, B. S., Ibrahim, M., & Hassan, H. A. (2024). Thalassemia: Pathophysiology, diagnosis, and advances in treatment. Thalassemia Reports, 14(4), 81-102.
https://doi.org/10.3390/thalassrep14040010
45. Khan, S. U., Khan, M. U., Khan, R., Iqbal, M., Khan, S., & Ullah, J. (2024). A survey of acute transfusion reactions in thalassemic patients in Pakistan: A single centre experience. Journal of Islamabad Medical & Dental College, 13(3), 458-463.
https://doi.org/10.35787/jimdc.v13i3.1044
46. Khan, H., Ghafoor, T., Shahbaz, N., Khattak, T. A., Rahim, U., & Awan, M. N. (2025). Outcome of Haematopoietic Stem Cell Transplant in Beta-Thalassemia Major: Single Centre Experience from a Low-and Middle-Income Country. Journal of the College of Physicians and Surgeons--Pakistan: JCPSP, 35(4), 513-518.
https://doi.org/10.29271/jcpsp.2025.04.513
47. Etemad, K., Mohseni, P., Aghighi, M., Bahadorimonfared, A., Hantooshzadeh, R., Taherpour, N., Piri, N., Sotoodeh Ghorbani, S., Malek, F., Kheiry, F., Khodami, A., Valadbeigi, T., & Hajipour, M. (2021). Quality of life and related factors in β-thalassemia patients. Hemoglobin, 45(4), 245-249.
https://doi.org/10.1080/03630269.2021.1965617
48. Tan, J. Y., Yeo, Y. H., Chan, K. H., Shaaban, H., & Guron, G. (2024). Causes of death and mortality trends in individuals with thalassemia in the United States, 1999-2020. Journal of Blood Medicine, 15, 331-339.
https://doi.org/10.2147/jbm.s470177
49. Musallam, K. M., Vitrano, A., Meloni, A., Pollina, W. A., Karimi, M., El-Beshlawy, A., Hajipour, M., Di Marco, V., Ansari, S. H., Filosa, A., Ricchi, P., Ceci, A., Daar, S., Vlachaki, E., Singer, S. T., Naserullah, Z. A., Pepe, A., Scondotto, S., Dardanoni, G., … Maggio, A. (2021). Survival and causes of death in 2,033 patients with non-transfusion-dependent β-thalassemia. Haematologica, 106(9), 2489-2492.
https://doi.org/10.3324/haematol.2021.278684
50. Iam-arunthai, K., Suwanban, T., Thungthong, P., Chamnanchanunt, S., & Fucharoen, S. (2024). Predicting factors of survival rates among alpha- and beta-thalassemia patients: A retrospective 10-year data analysis. Frontiers in Hematology, 3.
https://doi.org/10.3389/frhem.2024.1339026
51. Maryam, M., Rahman, A., & Haider, S. (2024). Investigation of the relationship between thalassemia and depression to predict a base for rehabilitation measures. Journal of Disability Research, 3(5).
https://doi.org/10.57197/jdr-2024-0045
52. Khan, M. A., Fazlul Aziz Mian, Subaat Basit, Bilqees, Laiba Sarfraz, & Shahjahan Wahid. (2025). Structural and hemodynamic changes on echocardiography in beta-thalassemia major patients. Insights-Journal of Health and Rehabilitation, 3(3 (Health & Allied)), 222-230.
https://doi.org/10.71000/3ts9cm74
53. Kattamis, A., Kwiatkowski, J. L., & Aydinok, Y. (2022). Thalassaemia. The Lancet, 399(10343), 2310-2324.
https://doi.org/10.1016/s0140-6736(22)00536-0
54. Lorey, F., Charoenkwan, P., Witkowska, H. E., Lafferty, J., Patterson, M., Eng, B., Waye, J. S., Finklestein, J. Z., & Chui, D. H. (2001). HB H hydrops foetalis syndrome: A case report and review of literature. British Journal of Haematology, 115(1), 72-78.
https://doi.org/10.1046/j.1365-2141.2001.03080.x
55. Lorey, F., Cunningham, G., Vichinsky, E. P., Lubin, B. H., Witkowska, H. E., Matsunaga, A., Azimi, M., Sherwin, J., Eastman, J., Farina, F., Waye, J. S., & Chui, D. H. (2001). Universal newborn screening for HB H disease in California. Genetic Testing, 5(2), 93-100.
https://doi.org/10.1089/109065701753145538
56. Weatherall, D. J., & Clegg, J. B. (2001). Inherited haemoglobin disorders: an increasing global health problem. Bulletin of the World Health Organization, 79(8), 704-712.
https://www.scielosp.org/pdf/bwho/v79n8/v79n8a05.pdf
57. Vichinsky, E. P. (2000). Report of proceedings: 1999 International Conference on E-β thalassemia. Journal of Pediatric Hematology/Oncology, 22(6), 550.
https://doi.org/10.1097/00043426-200011000-00020
58. Lorey, F. (2000). Asian immigration and public health in California: Thalassemia in newborns in California. Journal of Pediatric Hematology/Oncology, 22(6), 564-566.
https://doi.org/10.1097/00043426-200011000-00024
59. Musallam, K. M., Cappellini, M. D., Wood, J. C., Motta, I., Graziadei, G., Tamim, H., & Taher, A. T. (2011). Elevated liver iron concentration is a marker of increased morbidity in patients with thalassemia intermedia. Haematologica, 96(11), 1605-1612.
https://doi.org/10.3324/haematol.2011.047852
60. Vogiatzi, M. G., Macklin, E. A., Fung, E. B., Cheung, A. M., Vichinsky, E., Olivieri, N., Kirby, M., Kwiatkowski, J. L., Cunningham, M., Holm, I. A., Lane, J., Schneider, R., Fleisher, M., Grady, R. W., Peterson, C. C., & Giardina, P. J. (2009). Bone disease in thalassemia: A frequent and still unresolved problem. Journal of Bone and Mineral Research, 24(3), 543-557.
https://doi.org/10.1359/jbmr.080505
61. Musallam, K. M., Sankaran, V. G., Cappellini, M. D., Duca, L., Nathan, D. G., & Taher, A. T. (2012). Fetal hemoglobin levels and morbidity in untransfused patients with β-thalassemia intermedia. Blood, 119(2), 364-367.
https://doi.org/10.1182/blood-2011-09-382408
62. Limpawattana, P., Juntararuangtong, T., Teawtrakul, N., Wanitpongpun, C., Lanamtieng, T., Phiphitaporn, P., & Chansung, K. (2022). Cognitive impairment in thalassemia and associated factors. Dementia and Geriatric Cognitive Disorders, 51(2), 128-134.
https://doi.org/10.1159/000522655
63. Efat, A., Wahb, R., Shoeib, S. A., Dawod, A. A., Abd ElHafez, M. A., Abd ElMohsen, E. A., & Elkholy, A. (2022). GDF‐15 is associated with atherosclerosis in adults with transfusion‐dependent beta‐thalassemia. eJHaem, 3(2), 353-361.
https://doi.org/10.1002/jha2.415
64. Shamaoon, M., Nawaz, J., & Ahsan, M. (2018). β-THALASSEMIA MAJOR. The Professional Medical Journal, 25(06), 823-827.
https://doi.org/10.29309/tpmj/2018.25.06.265
65. Aslam, M. S., Roshan, E., Iqbal, A., & Shahid, M. (2013). FREQUENCY OF SHORT STATURE IN (Beta)-THALASSEMIA MAJOR PATIENTS. Pakistan Armed Forces Medical Journal, (4), 43.
66. Ahmed Kiani, R., Anwar, M., Waheed, U., Asad, M. J., Abbasi, S., & Abbas Zaheer, H. (2016). Epidemiology of transfusion transmitted infection among patients withβ-thalassaemia major in Pakistan. Journal of Blood Transfusion, 2016, 1-5.
https://doi.org/10.1155/2016/8135649
67. Mittal, K., Abrol, P., & Yadav, J. (2016). Prevalence of transfusion transmitted infections amongst multiple blood transfused patients of β-thalassemia major in a tertiary care hospital. International Journal of Research in Medical Sciences, 5(1), 181.
https://doi.org/10.18203/2320-6012.ijrms20164545
68. Salama, K., Khaled, H. Z., El Dien, H. M., Afifi, R. A., Shaheen, N. M., & El Wahab, M. A. (2022). Assessment of cardiac functions and arrhythmia in children with beta-thalassemia major and beta-thalassemia Intermedia. Open Access Macedonian Journal of Medical Sciences, 10(B), 890-895.
https://doi.org/10.3889/oamjms.2022.9026
69. Jafri, L., Jameel Farooqui, A., Moiz, B., Sheikh, A., Majid, H., Nadeem, S., Quddus, R., Khan, S., Khan, Q., & Habib Khan, A. (2025). Factors associated with phosphate homeostasis in children with beta-thalassemia major: An analytical cross sectional study from Pakistan. PLOS ONE, 20(2), e0316566.
https://doi.org/10.1371/journal.pone.0316566
70. Zareef, A., Ansar, F., Khan, A. A., Khan, M. T. M., & Shah, F. (2024). Assessment of growth retardation among transfusion-dependent Thalassemia patients in Peshawar, Pakistan. Khyber Medical University Journal, 16(3), 207-12.
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Indus Journal of Bioscience Research
This work is licensed under a Creative Commons Attribution 4.0 International License.
